(2RS,5SR,13ASR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUORO BENZYL)- 2,3,4,5,7,9,13,13AOCTAHYDRO-2,5-METHANO PYRIDO(1',2':4,5)PYRAZINO (2,1-B)(1,3)OXAZEPINE-10-CARBOXAMIDE
UNII PQH4B3ZQ47

Substance Identification & Data

This profile provides standardized clinical and technical data for (2rs,5sr,13asr)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluoro Benzyl)- 2,3,4,5,7,9,13,13aoctahydro-2,5-methano Pyrido(1',2':4,5)pyrazino (2,1-b)(1,3)oxazepine-10-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PQH4B3ZQ47.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2468639-05-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
PQH4B3ZQ47
CAS Registry Number
2468639-05-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
(2RS,5SR,13ASR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUORO BENZYL)- 2,3,4,5,7,9,13,13AOCTAHYDRO-2,5-METHANO PYRIDO(1',2':4,5)PYRAZINO (2,1-B)(1,3)OXAZEPINE-10-CARBOXAMIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C21H18F3N3O5
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
SOLUWJRYJLAZCX-USBNGQNGSA-N;SOLUWJRYJLAZCX-OHUAYANFSA-N
Line notation for describing the chemical structure and connectivity of atoms.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
[C@]12(N(C(c3n(C1)cc(c(c3O)=O)C(NCc4c(cc(cc4F)F)F)=O)=O)[C@H]5CC[C@@H](O2)C5)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for (2rs,5sr,13asr)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluoro Benzyl)- 2,3,4,5,7,9,13,13aoctahydro-2,5-methano Pyrido(1',2':4,5)pyrazino (2,1-b)(1,3)oxazepine-10-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(2RS,5SR,13ASR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUORO BENZYL)- 2,3,4,5,7,9,13,13AOCTAHYDRO-2,5-METHANO PYRIDO(1',2':4,5)PYRAZINO (2,1-B)(1,3)OXAZEPINE-10-CARBOXAMIDE
2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXAMIDE, 2,3,4,5,7,9,13,13A-OCTAHYDRO-8-HYDROXY-7,9-DIOXO-N-((2,4,6-TRIFLUOROPHENYL)METHYL)-, (2R,5S,13AS)-REL-

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record